Digital diagnostics company Ellume Inc., an Australian company with U.S. operations in Valencia, developed the first at-home COVID-19 test approved by the U.S. Food and Drug Administration.
Ellume’s test kit is priced at $30 and doesn’t require a prescription, great news for a populace facing stay-at-home orders and an overburdened health care system. ...

Join our Membership to get the full story.

Are you a current Member? Sign In